Science Explorer Back to mapMap
Discussion
Company · Oklahoma City · United States

Coare Biotechnology (United States)

coarebiotechnology.comROR OpenAlex
Research works
9
▼ 49% vs 2018-21
Citations
226
25.9 per fractional work
Top-10% rate
9.1%
all institutions 10.0%
Open access
67%
world 40%
International
13%
world 18%
Coare Biotechnology (United States)

Not ranked overall: Coare Biotechnology (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Coare Biotechnology (United States) work in?

In all years, 44% of research at Coare Biotechnology (United States) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (25%), Earth and Planetary Sciences (11%). It does 1.4× the world's share of Health Sciences.

Health Sciences: 4 fractional works · 43.6% of its workMedicine: 4 fractional works · 42.9% of its workOncology: 3 fractional works · 34.7% of its workPulmonary and Respiratory Medicine: 0 fractional works · 3.8% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 2.5% of its workSurgery: 0 fractional works · 1.3% of its workPathology and Forensic Medicine: 0 fractional works · 0.5% of its workNursing: 0 fractional works · 0.7% of its workNutrition and Dietetics: 0 fractional works · 0.7% of its workLife Sciences: 3 fractional works · 31.7% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 25.1% of its workMolecular Biology: 1 fractional works · 10.9% of its workCell Biology: 1 fractional works · 7.6% of its workCancer Research: 0 fractional works · 4.2% of its workGenetics: 0 fractional works · 1.3% of its workBiotechnology: 0 fractional works · 1.1% of its workAgricultural and Biological Sciences: 0 fractional works · 5.0% of its workPlant Science: 0 fractional works · 5.0% of its workImmunology and Microbiology: 0 fractional works · 1.5% of its workImmunology: 0 fractional works · 1.5% of its workPhysical Sciences: 1 fractional works · 15.3% of its workEarth and Planetary Sciences: 1 fractional works · 11.5% of its workGeochemistry and Petrology: 1 fractional works · 11.5% of its workEnvironmental Science: 0 fractional works · 3.8% of its workWater Science and Technology: 0 fractional works · 3.8% of its workSocial Sciences: 1 fractional works · 9.5% of its workBusiness, Management and Accounting: 0 fractional works · 5.7% of its workManagement Information Systems: 0 fractional works · 5.7% of its workSocial Sciences: 0 fractional works · 3.8% of its workAnthropology: 0 fractional works · 3.8% of its workALL ITS WORKCoareBiotechnology…9fractional works, all years
Life Sciences32%Physical Sciences15%Health Sciences44%Social Sciences10%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Medicine442.9%
    2. Nursing00.7%
    1. Biochemistry, Genetics and Molecular Biology225.1%
    2. Agricultural and Biological Sciences05.0%
    3. Immunology and Microbiology01.5%
    1. Earth and Planetary Sciences111.5%
    2. Environmental Science03.8%
    1. Business, Management and Accounting05.7%
    2. Social Sciences03.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Coare Biotechnology (United States)?

The most cited paper from Coare Biotechnology (United States) is "DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer" (Sripathi M. Sureban, Randal J. May, Dongfeng Qu et al., 2013), with 148 citations. Next come "XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism" (119) and "DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma" (113).

Most cited papers
#PaperReleasedCitations
1 DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer Sripathi M. Sureban, Randal J. May, Dongfeng Qu et al. · PLoS ONE Open access 9 Sep 2013 148
2 XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism Sripathi M. Sureban, Randal J. May, Nathaniel Weygant et al. · Cancer Letters 28 May 2014 119
3 DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma Nathaniel Weygant, Dongfeng Qu, Randal J. May et al. · Oncotarget Open access 11 Dec 2014 113
4 Alternative splice variants of DCLK1 mark cancer stem cells, promote self‐renewal and drug‐resistance, and can be targeted to inhibit tumorigenesis in kidney cancer Yang Ge, Nathaniel Weygant, Dongfeng Qu et al. · International Journal of Cancer Open access 26 Mar 2018 71
5 Ablation of Doublecortin-Like Kinase 1 in the Colonic Epithelium Exacerbates Dextran Sulfate Sodium-Induced Colitis Dongfeng Qu, Nathaniel Weygant, Randal J. May et al. · PLoS ONE Open access 18 Aug 2015 71
All 14 most cited papers, with filters and sorting

Which research topics does Coare Biotechnology (United States) publish most on?

By volume in 2022-now: Caveolin-1 and cellular processes and Cancer Cells and Metastasis.

  1. 1 Caveolin-1 and cellular processes Cell Biology 0 works
  2. 2 Cancer Cells and Metastasis Oncology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available66.8%not open33.2%

World: 40% of research is openly available.

with international co-authors12.9%domestic only87.1%

World: 18% is written across borders.

How has Coare Biotechnology (United States)'s research output changed?

Output in 2022-2025 was 49% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Coare Biotechnology (United States) as a percentage of every work published that year, 0.0000063% in 2022.

still counting0.00050%0.0010%Coare Biotechnology (United States)0.0000019% in 202519801990200020102020

Fractional works of Coare Biotechnology (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Oklahoma City

All research institutions in Oklahoma City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Coare Biotechnology (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.